. 2013 Sep 21;19(35):5904–5909. doi: 10.3748/wjg.v19.i35.5904

Table 3.

Anti-hepatitis B virus treatment in patients with liver failure in the hepatitis B virus + hepatitis E virus group

	Patients receiving anti-HBV treatment (n = 12)	Patients not receiving anti-HBV treatment (n = 30)	P value
HBV DNA (log₁₀ copies/mL)	4.99e7 ± 9.82e7	2.35e8 ± 9.20e8	0.495
MELD score	33.2 ± 9.4	28.3 ± 9.2	0.129
Mortality	8 (66.7)	53.3 (16/30)	0.506

Data are expressed as absolute n (%) or mean ± SD. HBV: Hepatitis B virus; HEV: Hepatitis E virus; MELD: Model for End-Stage Liver Disease.